Hard to believe they scammed The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services.
Development plan for Glioblastoma drug anticipates being prepared for First-in-Human clinical trial within 18 months. 18 months is around March 2022.
Still a window to develop.
We should direct questions to Michael K. Fish - Independent Director and Chairman of the Audit Committee. Would hope the licensed CPA has some integrity.
Market Data 
Markets 
AI
